Overview Dividends

(ENSG) The Ensign - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US29358P1012

Skilled Nursing, Senior Living, Rehabilitative Services, Property Leasing, Ancillary Services

EPS (Earnings per Share)

EPS CAGR: 15.63%
EPS Trend: 97.0%

Last SUE: 0.61σ
Qual. Beats: 0

Revenue

Revenue CAGR: 18.68%
Revenue Trend: 99.4%

Last SUE: 3.37σ
Qual. Beats: 2

Risk via 10d forecast
Volatility	23.6%
Value at Risk 5%th	36.5%
Relative Tail Risk	-5.90%

Reward TTM
Sharpe Ratio	0.84
Alpha	18.62

Character TTM
Hurst Exponent	0.651
Beta	0.479
Beta Downside	0.342

Drawdowns 3y
Max DD	23.49%
Mean DD	5.82%
Median DD	4.83%

Description: ENSG The Ensign November 04, 2025

The Ensign Group, Inc. (NASDAQ: ENSG) operates a diversified portfolio of post-acute and senior-living services across 15 U.S. states. Its business is split between the Skilled Services segment-delivering short- and long-term nursing care, specialty programs (dialysis, ventilator, cardiac, pulmonary), and ancillary diagnostics-and the Standard Bearer segment, which owns and leases post-acute care facilities to third-party operators while also managing senior-living units.

Key operating metrics that investors monitor include an average occupancy rate of roughly 84% across its skilled-nursing facilities (FY 2023) and a revenue growth rate of 6.2% year-over-year, driven in part by rising demand for chronic-care beds as the U.S. population ages. The sector’s profitability is tightly linked to Medicare and Medicaid reimbursement trends; recent CMS policy updates that increase per-day rates for high-complexity cases have bolstered ENSG’s margin outlook, with FY 2023 EBITDA margin reported at 12.5%.

For a deeper quantitative view of ENSG’s valuation metrics, you may find the ValueRay platform’s analyst toolkit useful.

ENSG Stock Overview

Market Cap in USD	10,340m
Sub-Industry	Health Care Facilities
IPO / Inception	2007-11-09
Return 12m vs S&P 500	12.4%
Analyst Rating	4.50 of 5

ENSG Dividends

Metric	Value
Dividend Yield	0.14%
Yield on Cost 5y	0.35%
Yield CAGR 5y	4.62%
Payout Consistency	96.9%
Payout Ratio	4.1%

ENSG Growth Ratios

Metric	Value
CAGR 3y	26.09%
CAGR/Max DD Calmar Ratio	1.11
CAGR/Mean DD Pain Ratio	4.49
Current Volume	433.8k
Average Volume	433.8k

Piotroski VR‑10 (Strict, 0-10) 7.5

Net Income (328.2m TTM) > 0 and > 6% of Revenue (6% = 289.8m TTM)

FCFTA 0.06 (>2.0%) and ΔFCFTA 1.37pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue 7.90% (prev 10.42%; Δ -2.52pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA 0.09 (>3.0%) and CFO 481.4m > Net Income 328.2m (YES >=105%, WARN >=100%)

Net Debt (1.71b) to EBITDA (538.7m) ratio: 3.18 <= 3.0 (WARN <= 3.5)

Current Ratio 1.46 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (59.0m) change vs 12m ago 0.88% (target <= -2.0% for YES)

Gross Margin 15.65% (prev 15.51%; Δ 0.14pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 98.00% (prev 88.76%; Δ 9.25pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio 53.02 (EBITDA TTM 538.7m / Interest Expense TTM 8.29m) >= 6 (WARN >= 3)

Altman Z'' 2.68

(A) 0.07 = (Total Current Assets 1.21b - Total Current Liabilities 825.2m) / Total Assets 5.23b

(B) 0.32 = Retained Earnings (Balance) 1.66b / Total Assets 5.23b

(D) 0.54 = Book Value of Equity 1.66b / Total Liabilities 3.10b

Total Rating: 2.68 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 81.25

1. Piotroski 7.50pt

2. FCF Yield 2.41%

3. FCF Margin 6.00%

4. Debt/Equity 1.02

5. Debt/Ebitda 3.18

6. ROIC - WACC (= 9.88)%

7. RoE 16.62%

8. Rev. Trend 99.39%

9. EPS Trend 97.03%

What is the price of ENSG shares?

As of November 25, 2025, the stock is trading at USD 184.58 with a total of 433,826 shares traded.
Over the past week, the price has changed by +3.95%, over one month by -0.79%, over three months by +8.64% and over the past year by +27.34%.

Is ENSG a buy, sell or hold?

The Ensign has received a consensus analysts rating of 4.50. Therefore, it is recommended to buy ENSG.

Strong Buy: 4
Buy: 1
Hold: 1
Sell: 0
Strong Sell: 0

What are the forecasts/targets for the ENSG price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	201.4	9.1%
Analysts Target Price	201.4	9.1%
ValueRay Target Price	227.9	23.5%

ENSG Fundamental Data Overview November 20, 2025

Market Cap USD = 10.34b (10.34b USD * 1.0 USD.USD)
P/E Trailing = 31.7616
P/E Forward = 24.5098
P/S = 2.1409
P/B = 4.853
P/EG = 1.6351
Beta = 0.851
Revenue TTM = 4.83b USD
EBIT TTM = 439.6m USD
EBITDA TTM = 538.7m USD
Long Term Debt = 138.6m USD (from longTermDebt, last quarter)
Short Term Debt = 115.0m USD (from shortTermDebt, last quarter)
Debt = 2.16b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.71b USD (from netDebt column, last quarter)
Enterprise Value = 11.99b USD (10.34b + Debt 2.16b - CCE 506.3m)
Interest Coverage Ratio = 53.02 (Ebit TTM 439.6m / Interest Expense TTM 8.29m)
FCF Yield = 2.41% (FCF TTM 289.5m / Enterprise Value 11.99b)
FCF Margin = 6.00% (FCF TTM 289.5m / Revenue TTM 4.83b)
Net Margin = 6.80% (Net Income TTM 328.2m / Revenue TTM 4.83b)
Gross Margin = 15.65% ((Revenue TTM 4.83b - Cost of Revenue TTM 4.07b) / Revenue TTM)
Gross Margin QoQ = 14.67% (prev 16.19%)
Tobins Q-Ratio = 2.29 (Enterprise Value 11.99b / Total Assets 5.23b)
Interest Expense / Debt = 0.09% (Interest Expense 1.97m / Debt 2.16b)
Taxrate = 21.28% (22.7m / 106.6m)
NOPAT = 346.0m (EBIT 439.6m * (1 - 21.28%))
Current Ratio = 1.46 (Total Current Assets 1.21b / Total Current Liabilities 825.2m)
Debt / Equity = 1.02 (Debt 2.16b / totalStockholderEquity, last quarter 2.12b)
Debt / EBITDA = 3.18 (Net Debt 1.71b / EBITDA 538.7m)
Debt / FCF = 5.92 (Net Debt 1.71b / FCF TTM 289.5m)
Total Stockholder Equity = 1.98b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.28% (Net Income 328.2m / Total Assets 5.23b)
RoE = 16.62% (Net Income TTM 328.2m / Total Stockholder Equity 1.98b)
RoCE = 20.80% (EBIT 439.6m / Capital Employed (Equity 1.98b + L.T.Debt 138.6m))
RoIC = 16.33% (NOPAT 346.0m / Invested Capital 2.12b)
WACC = 6.45% (E(10.34b)/V(12.50b) * Re(7.78%) + D(2.16b)/V(12.50b) * Rd(0.09%) * (1-Tc(0.21)))
Discount Rate = 7.78% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: 100.0 | Cagr: 1.21%
[DCF Debug] Terminal Value 77.70% ; FCFE base≈251.0m ; Y1≈241.3m ; Y5≈236.7m
Fair Price DCF = 72.82 (DCF Value 4.22b / Shares Outstanding 57.9m; 5y FCF grow -5.16% → 3.0% )
EPS Correlation: 97.03 | EPS CAGR: 15.63% | SUE: 0.61 | # QB: 0
Revenue Correlation: 99.39 | Revenue CAGR: 18.68% | SUE: 3.37 | # QB: 2

Additional Sources for ENSG Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle